Effects of anticoagulants used during blood collection on human platelet function.
May
Jane A
JA
Cardiovascular Medicine, Queen's Medical Centre, Nottingham, UK.
Heptinstall
Stanley
S
D000244:Adenosine Diphosphate / Q000378:metabolism; D000255:Adenosine Triphosphate / Q000378:metabolism; D000925:Anticoagulants / Q000494:pharmacology*; D001792:Blood Platelets / Q000187:drug effects* / Q000378:metabolism; D019343:Citric Acid / Q000494:pharmacology; D005260:Female; D006493:Heparin / Q000494:pharmacology; D006629:Hirudins / Q000494:pharmacology; D006801:Humans; D008565:Membrane Proteins / Q000037:antagonists & inhibitors; D010974:Platelet Aggregation / Q000187:drug effects* / Q000502:physiology; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000037:antagonists & inhibitors; D011247:Pregnancy; D058919:Purinergic P2 Receptor Antagonists; D058925:Receptors, Purinergic P2Y12; D013997:Time Factors
D000925:Anticoagulants; D006629:Hirudins; D008565:Membrane Proteins; C548576:P2RY12 protein, human; D019039:Platelet Glycoprotein GPIIb-IIIa Complex; D058919:Purinergic P2 Receptor Antagonists; D058925:Receptors, Purinergic P2Y12; D019343:Citric Acid; D000244:Adenosine Diphosphate; D000255:Adenosine Triphosphate; D006493:Heparin